Publications by authors named "Blessie Nelson"

Claim this Profile
P
Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.
Blessie Elizabeth Nelson, Filip Janku, Siqing Fu, Ecaterina E Dumbrava, David S Hong

Clin Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors.
Blessie E Nelson, Shaun O'Brien, Rahul A Sheth, David S Hong, Aung Naing

J Immunother Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decentralized Clinical Trials in Early Drug Development-A Framework Proposal.
Diogo J Silva, Blessie Elizabeth Nelson, Jordi Rodon

J Immunother Precis Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study.
Blessie Elizabeth Nelson, Jason Roszik, Jibran Ahmed, Carmelia Maria Noia Barretto, Mirella Nardo

Mol Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the Abscopal Phenomenon-Reply.
Blessie Elizabeth Nelson, Vivek Subbiah

Mol Cancer Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging TROP2 Antibody-Drug Conjugates in Solid Tumors.
Blessie Elizabeth Nelson, Funda Meric-Bernstam

Annu Rev Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors.
Blessie Elizabeth Nelson, Apostolia M Tsimberidou, Xueyao Fu, Siqing Fu, Vivek Subbiah

Oncologist· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies for mitigating adverse events related to selective RET inhibitors in patients with RET-altered cancers.
Mirella Nardo, Mohamed A Gouda, Blessie E Nelson, Carmelia M N Barreto, J Hoyt Slade

Cell Rep Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.
Mirella Nardo, Bulent Yilmaz, Blessie Elizabeth Nelson, Harrys A Torres, Lan Sun Wang

Oncologist· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications.
Mohamed A Gouda, Blessie E Nelson, Lars Buschhorn, Adam Wahida, Vivek Subbiah

Clin Cancer Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer.
Blessie Elizabeth Nelson, Sadia Saleem, Senthil Damodaran, Neeta Somaiah, Sarina Piha-Paul

Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the Abscopal Effect: Associated Tumor Histologic Subtypes and Biomarkers.
Blessie Elizabeth Nelson, Jacob J Adashek, Aakash Akshay Sheth, Vivek Subbiah

Mol Cancer Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma.
Blessie Elizabeth Nelson, Neha K Reddy, Jason T Huse, Behrang Amini, Mirella Nardo

NPJ Precis Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The abscopal effect in patients with cancer receiving immunotherapy.
Blessie Elizabeth Nelson, Jacob J Adashek, Steven H Lin, Vivek Subbiah

Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On target methods to induce abscopal phenomenon for Off-Target effects: From happenstance to happenings.
Blessie Elizabeth Nelson, Jacob J Adashek, Steven H Lin, Vivek Subbiah

Cancer Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study.
Blessie Elizabeth Nelson, Jason Roszik, Filip Janku, David S Hong, Shumei Kato

NPJ Precis Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectrum of Immune Checkpoint Inhibitor Anemias: Results From a Single Center, Early-Phase Clinical Trials Case Series Experience.
Blessie Elizabeth Nelson, Chinenye Lynette Ejezie, Bettzy A Stephen, Mirella Nardo, Erick Campbell

J Hematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer screenings during the COVID-19 pandemic: An analysis of public interest trends.
Benjamin Greiner, Shelby Tipton, Blessie Nelson, Micah Hartwell

Curr Probl Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-neoplastic inflammatory pseudotumor of the lung after immunotherapy for melanoma: A diagnostic pitfall on fine needle aspiration biopsy of lung.
Blessie Elizabeth Nelson, Angelina Hong, Ike Okereke, Avi Markowitz, Maurice Willis

Diagn Cytopathol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elucidation of Novel Molecular Targets for Therapeutic Strategies in Urothelial Carcinoma: A Literature Review.
Blessie Elizabeth Nelson, Angelina Hong, Bagi Jana

Front Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard-Dose Rituximab as Effective Therapy for Treating Malignancy-Related Hemophagocytic Lymphohistiocytosis in the Eldery: A Case Report.
Blessie Elizabeth Nelson, Angelina Hong, Mhair Dekmezian, Bagi Jana

Case Rep Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report.
Blessie Elizabeth Nelson, Shelby Tipton, Rohit Venkatesan

J Hematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD5+ Diffuse Large B-Cell Lymphoma With Leukemic Transformation: A Rare Case With Central Nervous System Involvement, Treated With R-CHOP and Intrathecal Methotrexate/Cytarabine.
Justin Cordova, Blessie Nelson, Ashley M Brizendine, Fatima Iqbal, Rohit Venkatesan

Cureus· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pink elephant in the room: Declining public interest in breast cancer and the impact of marketing efforts.
Benjamin Greiner, Marissa Lee, Blessie Nelson, Micah Hartwell

J Cancer Policy· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare presentation of growing teratoma syndrome in patient with remote history of testicular cancer resection.
Blessie Nelson, Dylan Warfield, Camilo Velasquez Mejia, John Patrick Walker

J Surg Case Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis